用“覆盖”法定量测定药物、天然产物和辐射的体外复制寿命延长活性。

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-09-01 DOI:10.21873/invivo.14055
Alejandro Mena Acra, Hiroshi Sakagami, Shin Uota, Masaaki Yoshihara, Shinji Kito, Maki Izawa, Yusei Ohtaka, Giichirou Nakaya, Yukari Koga-Ogawa, Tadamasa Nobesawa, Daisuke Ueda, Ryuichiro Suzuki
{"title":"用“覆盖”法定量测定药物、天然产物和辐射的体外复制寿命延长活性。","authors":"Alejandro Mena Acra, Hiroshi Sakagami, Shin Uota, Masaaki Yoshihara, Shinji Kito, Maki Izawa, Yusei Ohtaka, Giichirou Nakaya, Yukari Koga-Ogawa, Tadamasa Nobesawa, Daisuke Ueda, Ryuichiro Suzuki","doi":"10.21873/invivo.14055","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>With an increasing number of comorbid diseases, the number of drug intake by elderly people and their chances to X-ray exposure inevitably increase. However, it is unclear how these treatments affect longevity. Primary human diploid fibroblasts with limited life span have been used as a model system for the study of cellular senescence. Since <i>in vitro</i> aging is a long process, the colony formation assay has often been used to monitor the aging progression. However, this method cannot accurately quantitate the anti-aging activity of the test samples due to the heterogeneous size distribution of the colonies. Therefore, we developed a new \"overlay\" method for quantitating the <i>in vitro</i> replicative lifespan elongation (RLE) activity of substances of interest.</p><p><strong>Materials and methods: </strong>Cells were treated for 14 days with or without (as control) various concentrations of test samples in culture medium supplemented with fetal bovine serum (FBS), without medium changes, but overlayed with fresh medium to minimize the cell detachment and nutritional deprivation. From the dose-response curve, the elongation index of the survival time (EI) was calculated by the ratio of maximum viable cell number at the optimal concentration of the test sample to that of the control at Day 14.</p><p><strong>Results: </strong>In general, six human fibroblasts prepared from dermal, oral and lung tissues required higher concentrations of FBS than cancer cells. Dermal fibroblasts were selected as the target cells, based on their higher hormetic responses. Quercetin, hydrocortisone, sodium ascorbate, vanillic acid and vanillin showed higher EI values than estradiol, curcumin, resveratrol, phellamurin, sodium butylate and X-ray irradiation, but did not reach the levels of plant extracts.</p><p><strong>Conclusion: </strong>The present method may be useful to quantitate the RLE activity of external and internal factors alone or in combination, in the presence of an appropriate positive control.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 5","pages":"2534-2548"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396065/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quantification of <i>In Vitro</i> Replicative Lifespan Elongation Activity of Pharmaceuticals, Natural Products and Radiation Using the \\\"Overlay\\\" Method.\",\"authors\":\"Alejandro Mena Acra, Hiroshi Sakagami, Shin Uota, Masaaki Yoshihara, Shinji Kito, Maki Izawa, Yusei Ohtaka, Giichirou Nakaya, Yukari Koga-Ogawa, Tadamasa Nobesawa, Daisuke Ueda, Ryuichiro Suzuki\",\"doi\":\"10.21873/invivo.14055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>With an increasing number of comorbid diseases, the number of drug intake by elderly people and their chances to X-ray exposure inevitably increase. However, it is unclear how these treatments affect longevity. Primary human diploid fibroblasts with limited life span have been used as a model system for the study of cellular senescence. Since <i>in vitro</i> aging is a long process, the colony formation assay has often been used to monitor the aging progression. However, this method cannot accurately quantitate the anti-aging activity of the test samples due to the heterogeneous size distribution of the colonies. Therefore, we developed a new \\\"overlay\\\" method for quantitating the <i>in vitro</i> replicative lifespan elongation (RLE) activity of substances of interest.</p><p><strong>Materials and methods: </strong>Cells were treated for 14 days with or without (as control) various concentrations of test samples in culture medium supplemented with fetal bovine serum (FBS), without medium changes, but overlayed with fresh medium to minimize the cell detachment and nutritional deprivation. From the dose-response curve, the elongation index of the survival time (EI) was calculated by the ratio of maximum viable cell number at the optimal concentration of the test sample to that of the control at Day 14.</p><p><strong>Results: </strong>In general, six human fibroblasts prepared from dermal, oral and lung tissues required higher concentrations of FBS than cancer cells. Dermal fibroblasts were selected as the target cells, based on their higher hormetic responses. Quercetin, hydrocortisone, sodium ascorbate, vanillic acid and vanillin showed higher EI values than estradiol, curcumin, resveratrol, phellamurin, sodium butylate and X-ray irradiation, but did not reach the levels of plant extracts.</p><p><strong>Conclusion: </strong>The present method may be useful to quantitate the RLE activity of external and internal factors alone or in combination, in the presence of an appropriate positive control.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 5\",\"pages\":\"2534-2548\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396065/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.14055\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:随着合并症的增多,老年人药物摄入的数量和x线暴露的机会不可避免地增加。然而,目前尚不清楚这些治疗方法如何影响寿命。有限寿命的原代人二倍体成纤维细胞已被用作细胞衰老研究的模型系统。由于体外老化是一个漫长的过程,菌落形成试验经常被用来监测老化进程。然而,由于菌落的大小分布不均,该方法不能准确定量检测样品的抗衰老活性。因此,我们开发了一种新的“覆盖”方法来定量研究物质的体外复制寿命延长(RLE)活性。材料和方法:将细胞在添加胎牛血清(FBS)的培养基中分别添加或不添加不同浓度的测试样品(作为对照)处理14天,培养基不改变,但用新鲜培养基覆盖,以尽量减少细胞脱离和营养剥夺。在剂量-反应曲线上,以第14天被试样品在最佳浓度下的最大活细胞数与对照的最大活细胞数之比计算存活时间(EI)的延长指数。结果:一般来说,从皮肤、口腔和肺组织制备的六种人成纤维细胞比癌细胞需要更高浓度的FBS。真皮成纤维细胞被选为靶细胞,因为它们具有较高的辐射反应。槲皮素、氢化可的松、抗坏血酸钠、香草酸和香兰素的EI值高于雌二醇、姜黄素、白藜芦醇、茴香素、丁酸钠和x射线照射,但未达到植物提取物的水平。结论:在适当的阳性对照下,本方法可单独或联合测定内外部因素的RLE活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Quantification of <i>In Vitro</i> Replicative Lifespan Elongation Activity of Pharmaceuticals, Natural Products and Radiation Using the "Overlay" Method.

Quantification of <i>In Vitro</i> Replicative Lifespan Elongation Activity of Pharmaceuticals, Natural Products and Radiation Using the "Overlay" Method.

Quantification of <i>In Vitro</i> Replicative Lifespan Elongation Activity of Pharmaceuticals, Natural Products and Radiation Using the "Overlay" Method.

Quantification of In Vitro Replicative Lifespan Elongation Activity of Pharmaceuticals, Natural Products and Radiation Using the "Overlay" Method.

Background/aim: With an increasing number of comorbid diseases, the number of drug intake by elderly people and their chances to X-ray exposure inevitably increase. However, it is unclear how these treatments affect longevity. Primary human diploid fibroblasts with limited life span have been used as a model system for the study of cellular senescence. Since in vitro aging is a long process, the colony formation assay has often been used to monitor the aging progression. However, this method cannot accurately quantitate the anti-aging activity of the test samples due to the heterogeneous size distribution of the colonies. Therefore, we developed a new "overlay" method for quantitating the in vitro replicative lifespan elongation (RLE) activity of substances of interest.

Materials and methods: Cells were treated for 14 days with or without (as control) various concentrations of test samples in culture medium supplemented with fetal bovine serum (FBS), without medium changes, but overlayed with fresh medium to minimize the cell detachment and nutritional deprivation. From the dose-response curve, the elongation index of the survival time (EI) was calculated by the ratio of maximum viable cell number at the optimal concentration of the test sample to that of the control at Day 14.

Results: In general, six human fibroblasts prepared from dermal, oral and lung tissues required higher concentrations of FBS than cancer cells. Dermal fibroblasts were selected as the target cells, based on their higher hormetic responses. Quercetin, hydrocortisone, sodium ascorbate, vanillic acid and vanillin showed higher EI values than estradiol, curcumin, resveratrol, phellamurin, sodium butylate and X-ray irradiation, but did not reach the levels of plant extracts.

Conclusion: The present method may be useful to quantitate the RLE activity of external and internal factors alone or in combination, in the presence of an appropriate positive control.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信